Education
About Us
Working with TipRanks
Follow Us
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
KZIA Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KZIA Stock 12 Month Forecast
Average Price Target
$3.00
▼( -13.04% Downside)
| Highest Price Target$3.00 | Average Price Target$3.00 | Lowest Price Target$3.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Best Analysts Covering Kazia Therapeutics
1 Month
xxx
Success Rate
3/6 ratings generated profit
Average Return
-9.95%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -9.95% per trade.
3 Months
xxx
Success Rate
1/6 ratings generated profit
Average Return
-15.37%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 16.67% of your transactions generating a profit, with an average return of -15.37% per trade.
1 Year
Success Rate
0/6 ratings generated profit
Average Return
-52.78%
reiterated a buy rating 11 months ago
Copying Sean Lee CFA's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -52.78% per trade.
2 Years
xxx
Success Rate
0/6 ratings generated profit
Average Return
-85.00%
reiterated a xxx
rating 11 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -85.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KZIA Analyst Recommendation Trends
Rating
Jun 22
Aug 22
Apr 23
Jul 24
Feb 25
Strong Buy
0
0
0
0
0
Buy
3
2
2
2
4
Hold
0
3
3
3
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
5
5
5
4
Each month's total comprises the sum of three months' worth of ratings.
KZIA Financial Forecast
KZIA Stock Forecast FAQ
What is KZIA’s average 12-month price target, according to analysts?
Based on analyst ratings, Kazia Therapeutics Limited’s 12-month average price target is 3.00.
What is KZIA’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for KZIA, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KZIA a Buy, Sell or Hold?
Kazia Therapeutics Limited has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Kazia Therapeutics Limited’s price target?
The average price target for Kazia Therapeutics Limited is 3.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $3.00 ,the lowest forecast is $3.00. The average price target represents -13.04% Decrease from the current price of $3.45.
The highest analyst price target is $3.00 ,the lowest forecast is $3.00. The average price target represents -13.04% Decrease from the current price of $3.45.
What do analysts say about Kazia Therapeutics Limited?
Kazia Therapeutics Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of KZIA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.